“They could greatly improve the standard of care for several hundred million underserved patients around the world,” says Verseon’s CSO David Kita FREMONT, Calif., Jan. 24, 2024 /PRNewswire/ — Verseon is pleased to announce that the USPTO has issued a new patent, “Thrombin Inhibitors,…